Induction of nuclear translocation of constitutive androstane receptor by peroxisome proliferator-activated receptor α synthetic ligands in mouse liver

被引:32
|
作者
Guo, Dongsheng
Sarkar, Joy
Suino-Powell, Kelly
Xu, Yong
Matsumoto, Kojiro
Jia, Yuzhi
Yu, Songtao
Khare, Sonal
Haldar, Kasturi
Rao, M. Sambasiva
Foreman, Jennifer E.
Monga, Satdarshan P. S.
Peters, Jeffrey M.
Xu, H. Eric
Reddy, Janardan K.
机构
[1] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA
[2] Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA
[3] Penn State Univ, Dept Vet & Biomed Sci, Ctr Mol Toxicol & Carcinogenesis, University Pk, PA 16802 USA
[4] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA
关键词
D O I
10.1074/jbc.M707183200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Peroxisome proliferators activate nuclear receptor peroxisome proliferator-activated receptor alpha ( PPAR alpha) and enhance the transcription of several genes in liver. We report here that synthetic PPAR alpha ligands Wy-14,643, ciprofibrate, clofibrate, and others induce the nuclear translocation of constitutive androstane receptor (CAR) in mouse liver cells in vivo. Adeno-viral-enhanced green fluorescent protein-CAR expression demonstrated that PPAR alpha synthetic ligands drive CAR into the hepatocyte nucleus in a PPAR alpha- and PPAR beta-independent manner. This translocation is dependent on the transcription coactivator PPAR-binding protein but independent of coactivators PRIP and SRC-1. PPAR alpha ligand-induced nuclear translocation of CAR is not associated with induction of Cyp2b10 mRNA in mouse liver. PPAR alpha ligands interfered with coactivator recruitment to the CAR ligand binding domain and reduced the constitutive transactivation of CAR. Both Wy-14,643 and ciprofibrate occupied the ligand binding pocket of CAR and adapted a binding mode similar to that of the CAR inverse agonist androstenol. These observations, therefore, provide information for the first time to indicate that PPAR alpha ligands not only serve as PPAR alpha agonists but possibly act as CAR antagonists.
引用
收藏
页码:36766 / 36776
页数:11
相关论文
共 50 条
  • [21] A novel peroxisome proliferator-activated receptor responsive element-luciferase reporter mouse reveals gender specificity of peroxisome proliferator-activated receptor activity in liver
    Ciana, Paolo
    Biserni, Andrea
    Tatangelo, Laura
    Tiveron, Cecilia
    Sciarroni, Anna Floriana
    Ottobrini, Luisa
    Maggi, Adriana
    MOLECULAR ENDOCRINOLOGY, 2007, 21 (02) : 388 - 400
  • [22] Prostaglandins are weak ligands of the peroxisome proliferator-activated receptor γ (PPARγ).
    Ferry, G
    Bruneau, V
    Beauverger, P
    Goussard, M
    Rodriguez, M
    Levens, N
    Galizzi, JP
    Boutin, JA
    FASEB JOURNAL, 2000, 14 (08): : A1441 - A1441
  • [23] Evaluation of the Role of Peroxisome Proliferator-Activated Receptor (PPAR in Mouse Liver Tumor Induction by Trichloroethylene and Metabolites
    Corton, J. Christopher
    CRITICAL REVIEWS IN TOXICOLOGY, 2008, 38 (10) : 857 - 875
  • [24] Induction of apoptosis in multiple myeloma by ligands of peroxisome proliferator-activated receptor γ (PPAR-γ).
    Eucker, J
    Baengeroth, K
    Zavrski, I
    Krebbel, H
    Zang, CB
    Heider, U
    Jakob, C
    Elstner, E
    Possinger, K
    Sezer, O
    BLOOD, 2004, 104 (11) : 294B - 295B
  • [25] Ligands of the peroxisome proliferator-activated receptor-γ and heart failure
    Thiemermann, C
    BRITISH JOURNAL OF PHARMACOLOGY, 2004, 141 (01) : 1 - 3
  • [26] Peroxisome proliferator-activated receptor γ ligands and atherosclerosis:: ending the heartache
    Rosen, ED
    Spiegelman, BM
    JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (05): : 629 - 631
  • [27] Induction of Mouse UDP-Glucuronosyltransferase mRNA Expression in Liver and Intestine by Activators of Aryl-Hydrocarbon Receptor, Constitutive Androstane Receptor, Pregnane X Receptor, Peroxisome Proliferator-Activated Receptor α, and Nuclear Factor Erythroid 2-Related Factor 2
    Buckley, David B.
    Klaassen, Curtis D.
    DRUG METABOLISM AND DISPOSITION, 2009, 37 (04) : 847 - 856
  • [28] Role of peroxisome proliferator-activated receptorγ ligands in the vessel wallDie Rolle der Peroxisome proliferator-activated receptorγ-Liganden an der Gefäßwand
    Alicja Jozkowicz
    J. Dulak
    J. Nanobashvili
    M. Prager
    I. Huk
    European Surgery, 2002, 34 (2) : 121 - 126
  • [29] Peroxisome proliferator-activated receptor γ ligands suppress liver carcinogenesis induced by diethylnitrosamine in rats
    Guo, Yan-Tong
    Leng, Xi-Sheng
    Li, Tao
    Zhao, Jing-Ming
    Lin, Xi-Hou
    WORLD JOURNAL OF GASTROENTEROLOGY, 2004, 10 (23) : 3419 - 3423
  • [30] Peroxisome proliferator-activated receptor γ ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor γ-dependent mechanisms
    Polikandriotis, JA
    Mazzella, LJ
    Rupnow, HL
    Hart, CM
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (09) : 1810 - 1816